GOALS: To validate cut-off values of CD3 T-cell receptor gamma-delta chain (TCRγδ) intraepithelial lymphocyte (IEL) in the (differential) diagnosis of celiac disease (CD). BACKGROUND: CD is characterized by an increase in gamma-delta IEL (CD3TCRγδ IEL). STUDY: Percentages were determined by flow cytometric analysis of IELs from small bowel biopsies in 213 CD and 13 potential CD (PCD) patients and in total 112 controls. A cut-off value for percentages of CD3TCRγδ IEL to differentiate active CD and controls was obtained from a receiver operating characteristic curve and implemented in controls and PCD patients. RESULTS: Percentage of CD3TCRγδ IEL was significantly increased in the majority of CD patients, irrespective of the presence of villous atrophy. A cut-off value of 14% for CD3TCRγδ IEL resulted in 66.3% sensitivity and 96.6% specificity for CD diagnosis (area under the curve, 88.6%). CONCLUSIONS: A percentage of ≥14% CD3TCRγδ IEL has a high specificity for CD diagnosis and can be of diagnostic help in cases where diagnosis is not straightforward.
GOALS: To validate cut-off values of CD3 T-cell receptor gamma-delta chain (TCRγδ) intraepithelial lymphocyte (IEL) in the (differential) diagnosis of celiac disease (CD). BACKGROUND:CD is characterized by an increase in gamma-delta IEL (CD3TCRγδ IEL). STUDY: Percentages were determined by flow cytometric analysis of IELs from small bowel biopsies in 213 CD and 13 potential CD (PCD) patients and in total 112 controls. A cut-off value for percentages of CD3TCRγδ IEL to differentiate active CD and controls was obtained from a receiver operating characteristic curve and implemented in controls and PCDpatients. RESULTS: Percentage of CD3TCRγδ IEL was significantly increased in the majority of CDpatients, irrespective of the presence of villous atrophy. A cut-off value of 14% for CD3TCRγδ IEL resulted in 66.3% sensitivity and 96.6% specificity for CD diagnosis (area under the curve, 88.6%). CONCLUSIONS: A percentage of ≥14% CD3TCRγδ IEL has a high specificity for CD diagnosis and can be of diagnostic help in cases where diagnosis is not straightforward.
Authors: Kaninika Basu; Hannah Creasey; Nina Bruggemann; Jennifer Stevens; David Bloxham; Jeremy Mark Woodward Journal: Frontline Gastroenterol Date: 2021-04-20
Authors: Yousef R Badran; Angela Shih; Mari Mino-Kenudson; Michael Dougan; Donna Leet; Meghan J Mooradian; Alexandra Coromilas; Jonathan Chen; Marina Kem; Hui Zheng; Jennifer Borowsky; Joseph Misdraji Journal: J Immunother Cancer Date: 2020-06 Impact factor: 13.751
Authors: Cristina Camarero; Ana De Andrés; Carlota García-Hoz; Belén Roldán; Alfonso Muriel; Francisco León; Garbiñe Roy Journal: Clin Transl Gastroenterol Date: 2021-11-10 Impact factor: 4.488
Authors: Johannes Wolf; Edith Willscher; Henry Loeffler-Wirth; Maria Schmidt; Gunter Flemming; Marlen Zurek; Holm H Uhlig; Norman Händel; Hans Binder Journal: Int J Mol Sci Date: 2021-03-04 Impact factor: 5.923
Authors: Roy L J van Wanrooij; E Andra Neefjes-Borst; Hetty J Bontkes; Marco W J Schreurs; Anton W Langerak; Chris J J Mulder; Gerd Bouma Journal: Clin Transl Gastroenterol Date: 2021-08-01 Impact factor: 4.488